RayBiotech Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:RayBiotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10827
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
RayBiotech Inc (RayBiotech) is a life science company that provides proteins, antibodies and immunological kits. The company’s product categories include antibody arrays, glycobiology arrays, protein arrays, phosphorylation arrays, elisa, functional assays, antibodies and custom recombinant protein service, among others. It provides services such as testing services, custom services, peptoid services and other services. RayBiotech also offers biostatistics and bioinformatics, molecular biology services, assay development service, consulting service and reversed-phase hplc analysis, among others. The company offers proteomics tools for the advancement of basic and clinical research. RayBiotech is headquartered in Norcross, Georgia, the US.

RayBiotech Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RayBiotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
RayBiotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RayBiotech Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RayBiotech Enters Into Agreement With Abeome To Provide Monoclonal Antibodies 11
RayBiotech Enters Into Co-Marketing Agreement With Innopsys 12
Licensing Agreements 13
RayBiotech Enters Into Licensing Agreement With Emory University 13
RayBiotech Inc – Key Competitors 14
RayBiotech Inc – Key Employees 15
RayBiotech Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
RayBiotech Inc, Pharmaceuticals & Healthcare, Key Facts 2
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RayBiotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RayBiotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
RayBiotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RayBiotech Enters Into Agreement With Abeome To Provide Monoclonal Antibodies 11
RayBiotech Enters Into Co-Marketing Agreement With Innopsys 12
RayBiotech Enters Into Licensing Agreement With Emory University 13
RayBiotech Inc, Key Competitors 14
RayBiotech Inc, Key Employees 15

List of Figures
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
RayBiotech Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[RayBiotech Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avedro Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • Sojitz Corporation (2768):企業のM&A・提携動向(石油・ガス分野)
    Summary Sojitz Corporation (Sojitz) is a diversified general trading group. The company through its subsidiaries and affiliates holds interest in machinery; energy and metals; chemicals and functional materials; and consumer lifestyle businesses. It distributes automobiles and aircraft, develops pow …
  • WESCO International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' WESCO International, Inc. Merge …
  • Cavitation Technologies, Inc. (CVAT):企業の財務及び戦略的SWOT分析
    Summary Cavitation Technologies, Inc. (Cavitation) is an energy service company that develops and offers processing technologies. The company caters its technologies to edible oil refining, algal oil extraction and renewable fuel production, alcoholic beverage enhancement, water treatment and expedi …
  • Nuevolution AS(製薬・医療分野):企業M&A動向
    Summary Nuevolution A/S (Nuevolution) is a small molecule drug discovery company. It facilitates the identification of potent drug leads using Chemetics, a proprietary fragment-based drug discovery technology. The technology integrates molecular biology and organic chemistry for the rapid synthesis …
  • Whiting Petroleum Corporation (WLL)(石油・ガス分野):企業M&A動向
    Summary Whiting Petroleum Corporation (Whiting) is an oil and gas company. The company acquires, exploits and explores crude oil, natural gas and natural gas liquids. It has operations in the regions of Rocky Mountain, Permian Basin, Mid-Continent, Gulf Coast and Michigan regions of the US. Whiting’ …
  • PZ Cormay SA (CRM):企業財務及び戦略的SWOT分析
    Summary PZ Cormay SA (Cormay) is a medical diagnostic company that offers diagnostic reagents and advanced laboratory equipments. The company offers products such as reagents, analyzers, coagulation, electrophoresis, urinalysis, rapid tests, assay sheets, and blood control instruments and equipment. …
  • Shell Oil Products US:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Shell Oil Products US Mergers a …
  • Miraca Holdings Inc. (4544)(製薬・医療分野):企業M&A動向
    Summary Miraca Holdings Inc. (Miraca Holdings) is a pharmaceutical company. The company works through its business divisions, such as in vitro diagnostics, clinical laboratory testing and healthcare. It carries out tests for different purposes, such as diagnosis of diseases, identification of clinic …
  • Vistin Pharma AS (VISTIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies active pharmaceutical ingredients and solid dosage forms. The company’s products include opioids, an analgesics and antitussive; metformin, an API for the treatment of diabetes II; …
  • NetDimensions (Holdings) Limited (NETD):企業の財務及び戦略的SWOT分析
    Summary NetDimensions (Holdings) Limited (NetDimensions) is a software company that develops and provides learning and talent management software solutions. The company's products include learning management system, modern and practical performance management system, exam engine and cloud analytics. …
  • ThinSoft (Holdings), Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ThinSoft (Holdings), Inc. Merge …
  • Inversiones Nacionales de Turismo, S.A.:企業の戦略・SWOT・財務分析
    Inversiones Nacionales de Turismo, S.A. - Strategy, SWOT and Corporate Finance Report Summary Inversiones Nacionales de Turismo, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Nebraska Public Power District:企業のM&A・提携動向(発電分野)
    Summary Nebraska Public Power District (NPPD) is an electric utility that generates and delivers sustainable energy, and offers customer service. The utility offers services that include electric usage at home through calculation that include air conditioning cost, residential electric bill, heating …
  • UTS Biogastechnik GmbH:企業の戦略的SWOT分析
    UTS Biogastechnik GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • MCE AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MCE AG Mergers and Acquisitions …
  • NorthWestern Corporation:発電所・企業SWOT分析
    NorthWestern Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Woogene B&G Co, Ltd. (018620):企業概要、財務及び戦略的SWOT分析
    Summary Woogene B&G Co, Ltd. (Woogene B&G) is a pharmaceutical company. The company develops, manufactures and markets animal health products and veterinary medicines. It offers products through the divisions such as pharmaceuticals and nutraceuticals. Woogene B&G’s pharmaceuticals division offers p …
  • OpSource, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OpSource, Inc. Mergers and Acqu …
  • Emptoris, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Emptoris, Inc. Mergers and Acqu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆